<DOC>
	<DOCNO>NCT00931853</DOCNO>
	<brief_summary>Primary Objective : - To evaluate clinical efficacy Naturetti ( jelly sugar free ) - To test medication subject suffer chronic functional constipation 30 day use . Secondary Objectives : - To demonstrate clinical tolerability daily use ( repeated dos ) component study drug . The component evaluate adverse event occurrence classify possibly relate , probably relate definitely relate - To demonstrate clinical tolerability study medication continuous use second phase study - To identify adverse event relate study drug - To identify drug interaction .</brief_summary>
	<brief_title>Efficacy Tolerability Cassia Fistula Plus Senna Alexandrina Miller ( Sugar Free ) Chronic Functional Constipation ( CFC ) .</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Senna Extract</mesh_term>
	<mesh_term>Sennoside A &amp; B</mesh_term>
	<criteria>Inclusion criterion : Having chronic functional constipation ROME IIII criterion Having majority stool type 1 2 Bristol Stool Scale Female subject use effective contraceptive method 3 month sexually active reproductive stage ICF signature Be able understand agree undertake study procedure Having contraindication relate study drug To perform study visit . Exclusion criterion : Having previous history current neurological disorder and/or metabolic one Having constipation cause previous surgery Having intestinal obstruction include colon/rectum cancer Having endocrine disorder diabetes mellitus Having Irritable bowel syndrome inflammatory bowel disease Having multiple sclerosis Having Parkinsons disease Having Hirschsprungs disease dyssynergy defecation Continuous treatment follow : analgesic , anticholinergic ( antihistamine , antispasmodic , antidepressant , antipsychotic ) iron supplement aluminum , opiates , antihypertensive , calcium channel blocker ganglionic blocker Treatment laxative medication rescue medication study Patients could confirm chronic functional constipation phase I study Pregnancy breast feed woman Abnormal laboratory result , clinical result show significant Investigator Corporeal mass index &gt; 30 Patients participate clinical study within 30 day Unable fulfill questionnaire ( diary ) Any condition make impossible patient participates Investigator opinion . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>